Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Isosorbide Mononitrate in Intrauterine Growth Restriction
NCT05800938Phase 4Completed
- Sponsor
- Ain Shams University
- Start
- Jun 2022
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of isosorbide mononitrate in intrauterine growth restriction (IUGR), sponsored by Ain Shams University. Primary endpoint: Umbilical artery Doppler resistance index at 4 weeks. Started Jun 2022; status: completed.
02
Drugs
isosorbide mononitrate
03
Conditions
intrauterine growth restriction (IUGR)
Beyond the preview
Go deeper on NCT05800938.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05800938.